CN113262273A - 一种改善心脑血管病的中药保健组合物、其制备方法及应用 - Google Patents
一种改善心脑血管病的中药保健组合物、其制备方法及应用 Download PDFInfo
- Publication number
- CN113262273A CN113262273A CN202110762146.XA CN202110762146A CN113262273A CN 113262273 A CN113262273 A CN 113262273A CN 202110762146 A CN202110762146 A CN 202110762146A CN 113262273 A CN113262273 A CN 113262273A
- Authority
- CN
- China
- Prior art keywords
- cerebrovascular diseases
- cardiovascular
- chinese medicine
- traditional chinese
- care composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 208000026106 cerebrovascular disease Diseases 0.000 title claims abstract description 43
- 208000024172 Cardiovascular disease Diseases 0.000 title claims abstract description 39
- 230000002526 effect on cardiovascular system Effects 0.000 title claims abstract description 39
- 239000003814 drug Substances 0.000 title claims abstract description 30
- 239000000203 mixture Substances 0.000 title claims abstract description 29
- 238000002360 preparation method Methods 0.000 title claims abstract description 13
- 239000002994 raw material Substances 0.000 claims abstract description 24
- 241000222336 Ganoderma Species 0.000 claims abstract description 15
- 206010003119 arrhythmia Diseases 0.000 claims abstract description 6
- 230000006793 arrhythmia Effects 0.000 claims abstract description 6
- 201000001320 Atherosclerosis Diseases 0.000 claims abstract description 5
- 239000009636 Huang Qi Substances 0.000 claims abstract description 5
- 208000031226 Hyperlipidaemia Diseases 0.000 claims abstract description 5
- 208000031225 myocardial ischemia Diseases 0.000 claims abstract description 5
- 208000004476 Acute Coronary Syndrome Diseases 0.000 claims abstract description 4
- 206010007572 Cardiac hypertrophy Diseases 0.000 claims abstract description 4
- 206010008118 cerebral infarction Diseases 0.000 claims abstract description 4
- 208000029078 coronary artery disease Diseases 0.000 claims abstract description 4
- 238000002156 mixing Methods 0.000 claims description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 13
- 239000008187 granular material Substances 0.000 claims description 11
- 238000007873 sieving Methods 0.000 claims description 11
- 240000005373 Panax quinquefolius Species 0.000 claims description 9
- 235000003140 Panax quinquefolius Nutrition 0.000 claims description 9
- 230000036541 health Effects 0.000 claims description 9
- 244000124209 Crocus sativus Species 0.000 claims description 8
- 235000015655 Crocus sativus Nutrition 0.000 claims description 8
- 241001076416 Dendrobium tosaense Species 0.000 claims description 8
- 235000013974 saffron Nutrition 0.000 claims description 8
- 239000004248 saffron Substances 0.000 claims description 8
- 241000382455 Angelica sinensis Species 0.000 claims description 7
- 235000006533 astragalus Nutrition 0.000 claims description 6
- 238000001035 drying Methods 0.000 claims description 6
- 241000045403 Astragalus propinquus Species 0.000 claims description 5
- 238000001914 filtration Methods 0.000 claims description 5
- 239000012530 fluid Substances 0.000 claims description 5
- 238000005303 weighing Methods 0.000 claims description 5
- 239000002552 dosage form Substances 0.000 claims description 4
- 239000000284 extract Substances 0.000 claims description 4
- 238000010298 pulverizing process Methods 0.000 claims description 4
- 208000006029 Cardiomegaly Diseases 0.000 claims description 2
- 235000013376 functional food Nutrition 0.000 claims description 2
- 239000008280 blood Substances 0.000 abstract description 21
- 210000004369 blood Anatomy 0.000 abstract description 21
- 230000001737 promoting effect Effects 0.000 abstract description 11
- 230000000694 effects Effects 0.000 abstract description 9
- 230000017531 blood circulation Effects 0.000 abstract description 5
- 210000001835 viscera Anatomy 0.000 abstract description 5
- 206010033557 Palpitations Diseases 0.000 abstract description 4
- 230000003750 conditioning effect Effects 0.000 abstract description 3
- 230000017423 tissue regeneration Effects 0.000 abstract description 2
- 210000002216 heart Anatomy 0.000 description 9
- 235000009508 confectionery Nutrition 0.000 description 8
- 230000007812 deficiency Effects 0.000 description 7
- 230000036039 immunity Effects 0.000 description 7
- 230000001105 regulatory effect Effects 0.000 description 7
- 206010011224 Cough Diseases 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- 230000032683 aging Effects 0.000 description 6
- 230000036772 blood pressure Effects 0.000 description 6
- 239000000796 flavoring agent Substances 0.000 description 6
- 235000019634 flavors Nutrition 0.000 description 6
- 210000004185 liver Anatomy 0.000 description 6
- 210000004072 lung Anatomy 0.000 description 6
- 230000002708 enhancing effect Effects 0.000 description 5
- 210000003734 kidney Anatomy 0.000 description 5
- 230000000144 pharmacologic effect Effects 0.000 description 5
- 210000000952 spleen Anatomy 0.000 description 5
- 238000005728 strengthening Methods 0.000 description 5
- 230000002936 tranquilizing effect Effects 0.000 description 5
- 206010028980 Neoplasm Diseases 0.000 description 4
- 206010003549 asthenia Diseases 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 210000002784 stomach Anatomy 0.000 description 4
- 206010010774 Constipation Diseases 0.000 description 3
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 3
- 235000008331 Pinus X rigitaeda Nutrition 0.000 description 3
- 235000011613 Pinus brutia Nutrition 0.000 description 3
- 241000018646 Pinus brutia Species 0.000 description 3
- 229920002472 Starch Polymers 0.000 description 3
- 208000031971 Yin Deficiency Diseases 0.000 description 3
- 206010013781 dry mouth Diseases 0.000 description 3
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 3
- 239000008108 microcrystalline cellulose Substances 0.000 description 3
- 229940016286 microcrystalline cellulose Drugs 0.000 description 3
- 230000002107 myocardial effect Effects 0.000 description 3
- 230000007935 neutral effect Effects 0.000 description 3
- 238000000643 oven drying Methods 0.000 description 3
- 230000003647 oxidation Effects 0.000 description 3
- 238000007254 oxidation reaction Methods 0.000 description 3
- 239000007779 soft material Substances 0.000 description 3
- 235000019698 starch Nutrition 0.000 description 3
- 239000008107 starch Substances 0.000 description 3
- 201000000736 Amenorrhea Diseases 0.000 description 2
- 206010001928 Amenorrhoea Diseases 0.000 description 2
- 241000125175 Angelica Species 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 208000000059 Dyspnea Diseases 0.000 description 2
- 206010013975 Dyspnoeas Diseases 0.000 description 2
- 235000001287 Guettarda speciosa Nutrition 0.000 description 2
- 208000032843 Hemorrhage Diseases 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- 241000756042 Polygonatum Species 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- 231100000540 amenorrhea Toxicity 0.000 description 2
- 230000036528 appetite Effects 0.000 description 2
- 235000019789 appetite Nutrition 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- 230000000740 bleeding effect Effects 0.000 description 2
- 210000001124 body fluid Anatomy 0.000 description 2
- 239000010839 body fluid Substances 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 230000009084 cardiovascular function Effects 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 230000004217 heart function Effects 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 150000002632 lipids Chemical class 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 208000026435 phlegm Diseases 0.000 description 2
- 206010036067 polydipsia Diseases 0.000 description 2
- 230000002000 scavenging effect Effects 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010002660 Anoxia Diseases 0.000 description 1
- 241000976983 Anoxia Species 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 241001061264 Astragalus Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 208000000616 Hemoptysis Diseases 0.000 description 1
- 241000282414 Homo sapiens Species 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010021118 Hypotonia Diseases 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 206010021531 Impetigo Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 206010026749 Mania Diseases 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010038084 Rectocele Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- 206010040840 Skin erosion Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 206010053476 Traumatic haemorrhage Diseases 0.000 description 1
- 208000012886 Vertigo Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 206010047531 Visual acuity reduced Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 208000005946 Xerostomia Diseases 0.000 description 1
- 208000022531 anorexia Diseases 0.000 description 1
- 230000007953 anoxia Effects 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000002082 anti-convulsion Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940127219 anticoagulant drug Drugs 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 229940107666 astragalus root Drugs 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 210000004556 brain Anatomy 0.000 description 1
- 208000019902 chronic diarrheal disease Diseases 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- 206010061428 decreased appetite Diseases 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 208000017561 flaccidity Diseases 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 208000031169 hemorrhagic disease Diseases 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 208000023589 ischemic disease Diseases 0.000 description 1
- 230000000302 ischemic effect Effects 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 230000003859 lipid peroxidation Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 244000000010 microbial pathogen Species 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 230000036284 oxygen consumption Effects 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 230000002028 premature Effects 0.000 description 1
- 230000009325 pulmonary function Effects 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 208000013220 shortness of breath Diseases 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 238000010025 steaming Methods 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 210000004233 talus Anatomy 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 229940126680 traditional chinese medicines Drugs 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 150000003648 triterpenes Chemical class 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 231100000889 vertigo Toxicity 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L31/00—Edible extracts or preparations of fungi; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/074—Ganoderma
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/13—Coniferophyta (gymnosperms)
- A61K36/15—Pinaceae (Pine family), e.g. pine or cedar
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8969—Polygonatum (Solomon's seal)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/898—Orchidaceae (Orchid family)
- A61K36/8984—Dendrobium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
Abstract
本发明涉及一种改善心脑血管病的中药保健组合物、其制备方法及应用,所述改善心脑血管病的中药保健组合物的原料组分包括:黄芪、当归、西洋参、灵芝、西红花、松花粉、黄精、铁皮石斛。本发明所述的改善心脑血管病的中药保健组合物,具有较好的培补元气、调理脏腑、通行气血、祛瘀生新的作用。可以有效预防和改善包括心悸、气短、冠心病、心肌缺血、高脂血症、高粘血症、动脉粥样硬化、心肌肥厚、心律不齐、急性冠脉综合征、脑梗塞等在内的多种心脑血管病。
Description
技术领域
本发明属于中药保健技术领域,具体涉及一种改善心脑血管病的中药保健组合物、其制备方法及应用。
背景技术
心脑血管疾病是心脏血管和脑血管疾病的统称,泛指由于高脂血症、血液黏稠、动脉粥样硬化、高血压等所导致的心脏、大脑及全身组织发生的缺血性或出血性疾病。心脑血管疾病是一种严重威胁人类,特别是50岁以上中老年人健康的常见病,具有“发病率高、致残率高、死亡率高、复发率高、并发症多”——“四高一多”的特点,全世界每年死于心脑血管疾病的人数高达1500万人,居各种死因首位。
现有的防治心脑血管病的中药大多以活血化瘀为主,治疗效果具有一定的局限性,难以取得更进一步效果。
发明内容
为了解决现有技术中存在的上述问题,本发明提供一种改善心脑血管病的中药保健组合物及其制备方法,所述改善心脑血管病的中药保健组合物以8种药食同源的原料配合组方而成,通过培补元气、调理脏腑以固本,以通行气血、祛瘀生新辅助之,进而标本兼顾,能够较好地改善多种心脑血管病。
本发明的技术方案为:
本发明提供一种改善心脑血管病的中药保健组合物,原料组分包括:黄芪、当归、西洋参、灵芝、西红花、松花粉、黄精、铁皮石斛。优选的,按重量份计,包括以下原料:黄芪2-5重量份、当归1-4重量份、西洋参0.5-3重量份、灵芝0.5-3重量份、西红花0.25-2重量份、松花粉0.5-3重量份、黄精1-3重量份、铁皮石斛0.25-2重量份。
黄芪,味甘,性微温;归脾、肺经。益卫固表,补气升阳,托毒生肌,利水消肿。用于气虚乏力、食少便溏,中气下陷,久泻脱肛,自汁盗汗,血虚萎黄,阴疽漫肿,气虚水肿,内热消渴。药理作用包括增强免疫、抗衰老、抗病原微生物、镇静、促进机体代谢、抗肿瘤、改善心功能以及保肝的作用。
当归,味甘、辛,性温。归肝、心、脾经。活血止痛,补血调经,润肠通便。用于血虚眩晕,月经不调,经闭,痛经,面色萎黄,虚寒腹痛,跌打损伤,风湿痹痛,痈疽疮疡,肠燥便秘。药理作用包括增强免疫、抗炎、抗肿瘤、改善肺功能、抗菌、清除自由基、改善心血管功能、兴奋子宫以及镇静作用。
西洋参,味苦,微甘,性寒。归心、肺、肾经。补气养阴,清火生津。用于烦渴少气,口干舌燥,喘咳痰血。药理作用包括调节免疫、镇静、改善心血管功能、清除自由基以及强壮身体。
灵芝,味甘,性平;归心、肺、肝、肾经。补气安神,止咳平喘。用于心神不宁,失眠,惊悸,咳喘痰多,虚劳证。灵芝多糖具有免疫调节、降血糖、降血脂、抗氧化、抗衰老及抗肿瘤作用;三萜类化合物能净化血液,保护肝功能;灵芝多种制剂分别具有镇静、抗惊厥、强心、抗心律失常、降压、镇咳平喘作用;此外,灵芝还有抗凝血、抑制血小板聚集及抗过敏作用。
西红花,味甘,性平。归心、肝经。活血化瘀,凉血解毒,解郁安神。用于经闭症瘕,产后瘀阻,温毒发斑,忧郁痞闷,惊悸发狂。药理作用包括兴奋子宫、降血压等作用。
松花粉,味甘,性温。归肝、脾经。收敛止血,燥湿敛疮。用于外伤出血,湿疹,黄水疮,皮肤糜烂,脓水淋漓。药理作用包括抗疲劳、延缓衰老、美容、缓解便秘等。
黄精,味甘,性平。归脾、肺、肾经。补气养阴,健脾,润肺,益肾。用于脾胃气虚,体倦乏力,胃阴不足,口干食少,肺虚燥咳,劳嗽咳血,精血不足,腰膝酸软,须发早白,内热消渴。黄精有抗病塬微生物、降血糖、增加冠脉流量抗病毒、止血、抗疲劳、抗氧化、延缓衰老等作用等。
铁皮石斛,味甘、微寒。归胃、肾经。益胃生津,滋阴清热,用于热病津伤,口干烦渴,胃阴不足,食少于呕,病后虚热不退,阴虚火旺,骨蒸劳热,目暗不明,筋骨痿软。铁皮石斛有增强免疫功能、促进人体消化系统、护肝利胆促肝功能代谢、抗风湿、降血糖、降血脂、降血压、抗肿瘤、保护视力、滋养肌肤以及抗衰老的作用。
本发明所述的改善心脑血管病的中药保健组合物,还可以通过加入药用辅料,按照一般制剂学方法制备成为适合药用的任何药物剂型,包括但不限于颗粒剂、片剂、口服液,优选为颗粒剂。
本发明还提供一种前述改善心脑血管病的中药保健组合物颗粒剂的制备方法,包括如下步骤:按重量份称取各原料,将所述各原料混合后加水煎煮两次,优选的,所述混合后的原料与水之间的重量比为1:5-9,合并煎液;将煎液滤过后浓缩为清膏,优选的,采用减压浓缩至60℃下相对密度为1.12~1.25的清膏,然后依次进行干燥、粉碎、过筛,完毕后加入药学上可接受的载体混合均匀,经过筛、制粒、整粒,即得所述改善心脑血管病的中药保健组合物颗粒剂。
本发明还涉及所述的中药保健组合物在制备改善心脑血管病的功能食品中的应用。所述心脑血管病包括但不限于脑梗塞、冠心病、心肌缺血、高脂血症、高粘血症、动脉粥样硬化、心肌肥厚、心律不齐、急性冠脉综合征。
本发明的有益效果为:
1、本发明所述的改善心脑血管病的中药保健组合物,中医组方机理在于,通过采用黄芪、当归、西洋参、灵芝、西红花、松花粉、黄精、铁皮石斛为原料并进行适合的重量配比,其中,重用黄芪、西洋参、灵芝、黄精补益五脏之气,调理五脏虚损,扶正祛邪,以当归、西红花、松花粉、铁皮石斛通腑化瘀以推陈出新,最终制备得到的中药保健组合物,具有较好的培补元气、调理脏腑、通行气血、祛瘀生新的作用。
2、本发明所述的改善心脑血管病的中药保健组合物,从现代药理来说,黄芪、松花粉含有多种抗氧化成分,能对抗多种自由基,防止脂质过氧化;当归能扩张冠状动脉,增强冠脉流量、降低心肌耗氧量、改善微循环;西洋参、西红花抗心律失常,并加强当归抗心肌缺血、抗心肌氧化、强化心肌收缩能力,同时调节血压;灵芝可辅助增强当归的强心作用以及西洋参的调节血压的作用。黄精、铁皮石斛具有辅助降血糖、增强心肌耐缺氧以及调节免疫的作用。最终制备得到的中药保健组合物,具有较好的护心、强心、改善心功能、调节血压以及调节免疫的作用。
3、本发明所述的改善心脑血管病的中药保健组合物,可以有效预防和改善包括心悸、气短、冠心病、心肌缺血、高脂血症、高粘血症、动脉粥样硬化、心肌肥厚、心律不齐、急性冠脉综合征、脑梗塞等在内的多种心脑血管病。本发明可作为日常保健服用,具有安全无副作用,服用方便、经济实惠、适用人群广的特点。
具体实施方式
为使本发明的目的、技术方案和优点更加清楚,下面将对本发明的技术方案进行详细的描述。显然,所描述的实施例仅仅是本发明的一部分实施例,而不是全部的实施例。基于本发明中的实施例,本领域普通技术人员在没有做出创造性劳动的前提下所得到的所有其它实施方式,都属于本发明所保护的范围。以下实施例中以1重量份代表1g。
实施例1
本实施例提供一种改善心脑血管病的中药保健颗粒剂,包括以下重量份的原料:黄芪2重量份、当归4重量份、西洋参0.5重量份、灵芝3重量份、西红花0.25重量份、松花粉3重量份、黄精1重量份、铁皮石斛2重量份。
制备方法为:按重量份称取各原料,将所述各原料混合后加水煎煮两次,第一次加入8倍重量的水,煎煮时间为70min,第二次加入5倍重量的水,煎煮时间为30min,合并煎液;将煎液滤过后减压浓缩至60℃下相对密度为1.15的清膏,然后依次进行干燥、粉碎、过80目筛,完毕后加入微晶纤维素、淀粉混合均匀,然后加入体积浓度为80%的乙醇制软材,将所得软材过16目筛网制粒后,置于烘箱55℃烘干,14目筛网整粒,即得所述改善心脑血管病的中药保健组合物颗粒剂。
实施例2
本实施例提供一种改善心脑血管病的中药保健颗粒,包括以下重量份的原料:黄芪5重量份、当归1重量份、西洋参3重量份、灵芝0.5重量份、西红花2重量份、松花粉0.5重量份、黄精3重量份、铁皮石斛0.25重量份。
制备方法为:按重量份称取各原料,将所述各原料混合后加水煎煮两次,第一次加入9倍重量的水,煎煮时间为80min,第二次加入6倍重量的水,煎煮时间为35min,合并煎液;将煎液滤过后减压浓缩至相对密度为60℃下1.25的清膏,然后依次进行干燥、粉碎、过80目筛,完毕后加入微晶纤维素、淀粉混合均匀,然后加入体积浓度为80%的乙醇制软材,将所得软材过16目筛网制粒后,置于烘箱55℃烘干,14目筛网整粒,即得所述改善心脑血管病的中药保健组合物颗粒剂。
实施例3
本实施例提供一种改善心脑血管病的中药保健颗粒,包括以下重量份的原料:黄芪3重量份、当归2重量份、西洋参2重量份、灵芝1重量份、西红花1重量份、松花粉2重量份、黄精2重量份、铁皮石斛0.5重量份。
制备方法为:按重量份称取各原料,将所述各原料混合后加水煎煮两次,第一次加入7倍重量的水,煎煮时间为55min,第二次加入5倍重量的水,煎煮时间为30min,合并煎液;将煎液滤过后减压浓缩至相对密度为60℃下1.12的清膏,然后依次进行干燥、粉碎、过80目筛,完毕后加入微晶纤维素、淀粉混合均匀,然后加入体积浓度为80%的乙醇制软材,将所得软材过16目筛网制粒后,置于烘箱55℃烘干,14目筛网整粒,即得所述改善心脑血管病的中药保健组合物颗粒剂。
以上所述,仅为本发明的具体实施方式,但本发明的保护范围并不局限于此,任何熟悉本技术领域的技术人员在本发明揭露的技术范围内,可轻易想到变化或替换,都应涵盖在本发明的保护范围之内。因此,本发明的保护范围应以所述权利要求的保护范围为准。
Claims (8)
1.一种改善心脑血管病的中药保健组合物,其特征在于,原料组分包括:黄芪、当归、西洋参、灵芝、西红花、松花粉、黄精、铁皮石斛。
2.根据权利要求1所述的改善心脑血管病的中药保健组合物,其特征在于,包括以下重量份的原料:黄芪2-5重量份、当归1-4重量份、西洋参0.5-3重量份、灵芝0.5-3重量份、西红花0.25-2重量份、松花粉0.5-3重量份、黄精1-3重量份、铁皮石斛0.25-2重量份。
3.根据权利要求1所述的改善心脑血管病的中药保健组合物,其特征在于,所述中药保健组合物的剂型为适合药用的任何药物剂型。
4.根据权利要求3所述的改善心脑血管病的中药保健组合物,其特征在于,所述中药保健组合物的剂型为颗粒剂。
5.权利要求4所述改善心脑血管病的中药保健组合物颗粒剂的制备方法,其特征在于,包括如下步骤:
按重量份称取各原料,将所述各原料混合后加水煎煮两次,合并煎液;将煎液滤过后浓缩为清膏,然后依次进行干燥、粉碎、过筛,完毕后加入药学上可接受的载体混合均匀,经过筛、制粒、整粒,即得所述改善心脑血管病的中药保健组合物颗粒剂。
6.根据权利要求5所述改善心脑血管病的中药保健组合物颗粒剂的制备方法,其特征在于,所述混合后的原料与水之间的重量比为1:5-9,所述浓缩为减压浓缩至60℃下相对密度为1.12~1.25的清膏。
7.权利要求1-4任一项所述的中药保健组合物在制备改善心脑血管病的功能食品中的应用。
8.根据权利要求7所述的应用,其特征在于,所述心脑血管病为脑梗塞、冠心病、心肌缺血、高脂血症、高粘血症、动脉粥样硬化、心肌肥厚、心律不齐、急性冠脉综合征。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110762146.XA CN113262273A (zh) | 2021-07-06 | 2021-07-06 | 一种改善心脑血管病的中药保健组合物、其制备方法及应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110762146.XA CN113262273A (zh) | 2021-07-06 | 2021-07-06 | 一种改善心脑血管病的中药保健组合物、其制备方法及应用 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN113262273A true CN113262273A (zh) | 2021-08-17 |
Family
ID=77236467
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110762146.XA Pending CN113262273A (zh) | 2021-07-06 | 2021-07-06 | 一种改善心脑血管病的中药保健组合物、其制备方法及应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN113262273A (zh) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106138756A (zh) * | 2016-08-24 | 2016-11-23 | 苏宝艳 | 养护心脑血管的中药制剂 |
CN106937991A (zh) * | 2017-02-14 | 2017-07-11 | 四川双鑫生物科技有限公司 | 一种用于治疗心脑血管疾病的汤剂药物及其制备方法 |
CN109497388A (zh) * | 2019-01-18 | 2019-03-22 | 杜明华 | 一种心脑血管疾病的预防和辅助的药物 |
-
2021
- 2021-07-06 CN CN202110762146.XA patent/CN113262273A/zh active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106138756A (zh) * | 2016-08-24 | 2016-11-23 | 苏宝艳 | 养护心脑血管的中药制剂 |
CN106937991A (zh) * | 2017-02-14 | 2017-07-11 | 四川双鑫生物科技有限公司 | 一种用于治疗心脑血管疾病的汤剂药物及其制备方法 |
CN109497388A (zh) * | 2019-01-18 | 2019-03-22 | 杜明华 | 一种心脑血管疾病的预防和辅助的药物 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104873938A (zh) | 益精养血驻颜酒 | |
CN104984256A (zh) | 用于治疗湿热瘀阻型痛经的药物 | |
CN105560386B (zh) | 仙人掌片剂及其制备方法 | |
CN103933405A (zh) | 用于治疗气血两虚型烧伤的药物组合物及其制备方法 | |
CN102579813A (zh) | 一种防脱生发内服中药组合物 | |
CN102038832A (zh) | 一种治疗头皮屑的中药 | |
CN103705733B (zh) | 一种治疗心律不齐的中药胶囊及其制备方法 | |
CN103263582A (zh) | 一种减肥药方 | |
CN113262273A (zh) | 一种改善心脑血管病的中药保健组合物、其制备方法及应用 | |
CN113633722A (zh) | 一种治疗冠心病、心律失常的中药组合物及其制备方法 | |
CN106344859A (zh) | 一种鹿花盘胸部护理组合物 | |
CN104383222A (zh) | 治疗冠心病的中药酒 | |
CN104857121A (zh) | 一种治疗高血脂症的药物组合物及其应用 | |
CN104013810A (zh) | 一种治疗精索静脉曲张的中药组合物 | |
CN103463463A (zh) | 一种补血活血、祛风除湿的中药制剂 | |
CN108853413A (zh) | 一种具有益气补血功效的药食同源组合物及其制备方法 | |
CN116459314B (zh) | 一种延缓衰老喷剂 | |
CN107485698A (zh) | 一种具有养血通络、美容养颜功效的中药组合物及其制备方法 | |
CN1634539A (zh) | 一种治疗内科虚症的中药制剂 | |
CN105031562A (zh) | 活血润燥酒 | |
CN105663758A (zh) | 一种含有艾叶的治疗月经不调的中药组合物及其制备方法 | |
CN105456933A (zh) | 一种活血化瘀、通经活络的中药及其制备方法 | |
CN106138764A (zh) | 一种治疗冠心病及预防脑中风的纯中药制剂与制备方法 | |
CN105363000A (zh) | 丹参附子药酒 | |
CN105288385A (zh) | 蝉蜕中药酒 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20210817 |